Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 11117, December 1, 2007. doi: 10.1158/0008-5472.CAN-07-3028
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ridpath, J. R.
Right arrow Articles by Nakamura, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ridpath, J. R.
Right arrow Articles by Nakamura, J.

Priority Reports

Cells Deficient in the FANC/BRCA Pathway Are Hypersensitive to Plasma Levels of Formaldehyde

John R. Ridpath1, Ayumi Nakamura1,3, Keizo Tano4, April M. Luke2, Eiichiro Sonoda5, Hiroshi Arakawa6, Jean-Marie Buerstedde6, David A.F. Gillespie7, Julian E. Sale8, Mitsuyoshi Yamazoe5, Douglas K. Bishop9, Minoru Takata10, Shunichi Takeda5, Masami Watanabe4, James A. Swenberg1,2 and Jun Nakamura1

1 Department of Environmental Sciences and Engineering, and 2 Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 3 College of Arts and Sciences, University of Virginia, Charlottesville, Virginia; 4 Research Reactor Institute, Kyoto University, Kumatori, Japan; 5 Department of Radiation Genetics Graduate School of Medicine, Kyoto, Japan; 6 GSF-National Research Center for Environment and Health, Institute for Molecular Radiobiology, Neuherberg-Munich, Germany; 7 Beatson Institute for Cancer Research, Glasgow, United Kingdom; 8 Medical Research Council Laboratory of Molecular Biology, Division of Protein and Nucleic Acid Chemistry, Cambridge, United Kingdom; 9 Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois; and 10 Department of Human Genetics, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

Requests for reprints: Jun Nakamura, Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599. Phone: 919-966-6140; Fax: 919-966-6123; E-mail: ynakamur{at}email.unc.edu.

Formaldehyde is an aliphatic monoaldehyde and is a highly reactive environmental human carcinogen. Whereas humans are continuously exposed to exogenous formaldehyde, this reactive aldehyde is a naturally occurring biological compound that is present in human plasma at concentrations ranging from 13 to 97 µmol/L. It has been well documented that DNA-protein crosslinks (DPC) likely play an important role with regard to the genotoxicity and carcinogenicity of formaldehyde. However, little is known about which DNA damage response pathways are essential for cells to counteract formaldehyde. In the present study, we first assessed the DNA damage response to plasma levels of formaldehyde using chicken DT40 cells with targeted mutations in various DNA repair genes. Here, we show that the hypersensitivity to formaldehyde is detected in DT40 mutants deficient in the BRCA/FANC pathway, homologous recombination, or translesion DNA synthesis. In addition, FANCD2-deficient DT40 cells are hypersensitive to acetaldehyde, but not to acrolein, crotonaldehyde, glyoxal, and methylglyoxal. Human cells deficient in FANCC and FANCG are also hypersensitive to plasma levels of formaldehyde. These results indicate that the BRCA/FANC pathway is essential to counteract DPCs caused by aliphatic monoaldehydes. Based on the results obtained in the present study, we are currently proposing that endogenous formaldehyde might have an effect on highly proliferating cells, such as bone marrow cells, as well as an etiology of cancer in Fanconi anemia patients. [Cancer Res 2007;67(23):11117–22]




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Nakano, A. Katafuchi, M. Matsubara, H. Terato, T. Tsuboi, T. Masuda, T. Tatsumoto, S. P. Pack, K. Makino, D. L. Croteau, et al.
Homologous Recombination but Not Nucleotide Excision Repair Plays a Pivotal Role in Tolerance of DNA-Protein Cross-links in Mammalian Cells
J. Biol. Chem., October 2, 2009; 284(40): 27065 - 27076.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
A. M. H. Salem, T. Nakano, M. Takuwa, N. Matoba, T. Tsuboi, H. Terato, K. Yamamoto, M. Yamada, T. Nohmi, and H. Ide
Genetic Analysis of Repair and Damage Tolerance Mechanisms for DNA-Protein Cross-Links in Escherichia coli
J. Bacteriol., September 15, 2009; 191(18): 5657 - 5668.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
S MASUNAGA, K TANO, M WATANABE, G KASHINO, M SUZUKI, Y KINASHI, K ONO, and J NAKAMURA
Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with {gamma}-irradiation and cisplatin treatment in vivo
Br. J. Radiol., May 1, 2009; 82(977): 392 - 400.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.